The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.75
Bid: 34.00
Ask: 34.30
Change: -0.35 (-1.03%)
Spread: 0.30 (0.882%)
Open: 34.40
High: 34.40
Low: 33.70
Prev. Close: 34.10
IQE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IQE news update from CS-Mantech conference

17 May 2016 07:00

RNS Number : 3861Y
IQE PLC
17 May 2016
 

 

 

 

IQE transfers cREO™ growth capability to its North Carolina facility and demonstrates interface charge tuning using cREO™ for GaN products 

 

Cardiff, 17 May, 2016: 17 May 2016: IQE plc (AIM: IQE, "IQE" or the "Group"), the leading manufacturer of advanced semiconductor wafer products for the global semiconductor industry, announces two key developments at this year's CS MANTECH conference.

 

Successful transfer of cREO™ growth technology to North Carolina facility

IQE has successfully transferred Translucent's MBE equipment and associated process to its North Carolina facility.

Following the exclusive license of cREO™ Technology from Translucent in September 2015, IQE has successfully transferred two of Translucent's reactors to its facility in Greensboro, North Carolina. The first of these systems (production tool) has been installed and is now producing cREO™ templates on Si. The template structural and morphological characteristics are an excellent match to previously achieved results by Translucent. The second (R&D) tool is due to be online in approximately 1 month.

The production tool will produce standard templates for the IQE group and select partners, with initial focus on III-N materials.

Demonstration of interface charge tuning using cREO™ for GaN products

Using cREO™ templates IQE has demonstrated that it is able to tune the interfacial characteristics for GaN on Si. For RF applications, GaN on Si typically exhibits an undesirable p-type channel at the GaN / Si interface (AKA parasitic channel) that detrimentally affects RF efficiency.

Using its patented technology, IQE has demonstrated that the parasitic channel can be completely eliminated. In addition, IQE has shown that growth conditions can be tuned to generate and rationally engineer an n-type layer between the GaN and Si. This enables applications that require buried conductors for III-N on Si applications.

Dr. Rodney Pelzel, VP, IQE Group Technology commented:

"We are delighted to announce the transfer of the cREO™ process to our North Carolina facility. Materials produced on the newly installed tools clearly demonstrate the successful transfer of the technology.

"We have demonstrated that we are able to rationally manipulate the cREO™ characteristics to tune the conductivity of the III-N / Si interface. This is a significant enabler for GaN HEMT technology on Si for RF applications. In addition, it is an enabler for other III-N technology on Si such as RF filter technology.

"IQE is committed to fully exploiting cREO™ technology for GaN as well as other III-V and group IV materials. This technology offers exciting opportunities for fully realizing III-V growth on Si thereby eliminating the cost-prohibitive issue with native substrates such as InP. Furthermore, it enables heterointegration at the epi-level allowing previously incompatible materials systems to be successfully combined. cREO™ is an excellent complement to IQE's well-established wireless, photonics, power, and CMOS products and will enable novel solutions for our customers."

IQE is attending and exhibiting at CS MANTECH 2016 conference, 16th to 18th May.

 

Contacts

IQE

IQE plc, UK +44 (0) 29 2083 9400

Chris Meadows (Press/investors)

 

IQE USA +1 508 824 6696

Rodney Pelzel (Technical)

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEASSKFEAKEFF
Date   Source Headline
31st Jul 20064:07 pmRNSDirectors' Dealings
27th Jul 20062:47 pmRNSGrant of share options
20th Jul 20067:02 amRNSTrading Statement
20th Jul 20067:01 amRNSAcquisition
7th Jul 20062:46 pmRNSChange of Adviser
5th Jun 200610:32 amRNSDirector/PDMR Shareholding
30th May 20067:01 amRNSTrading Update
23rd May 200612:58 pmRNSAdditional Listing
19th May 20062:59 pmRNSHolding(s) in Company
8th May 20061:00 pmRNSAGM Notice & Board Appt
3rd May 20068:49 amRNSHolding(s) in Company
21st Apr 20066:01 pmRNSAdditional Listing
4th Apr 200612:45 pmRNSAdditional Listing
30th Mar 20064:25 pmRNSHolding(s) in Company
29th Mar 20061:51 pmRNSDirector/PDMR Shareholding
28th Mar 200611:27 amRNSHolding(s) in Company
20th Mar 20067:01 amRNSFinal Results
10th Mar 20064:33 pmRNSChange of Results Date
1st Mar 20067:01 amRNSNotice of Results
27th Jan 20067:01 amRNSContract Win
27th Jan 20067:01 amRNSPre-Close Trading Update
20th Dec 200511:58 amRNSAdditional Listing
26th Oct 20052:06 pmRNSHolding(s) in Company
20th Oct 20053:57 pmRNSDirector/PDMR Shareholding
10th Oct 20059:38 amRNSDirector/PDMR Shareholding
12th Sep 20053:09 pmRNSHolding(s) in Company
24th Aug 20057:00 amRNSInterim Results
19th Aug 200511:46 amRNSAdditional Listing
29th Jul 20057:00 amRNSNotice of Results
22nd Jul 20055:23 pmRNSHolding(s) in Company
20th Jul 20051:17 pmRNSHolding(s) in Company
19th Jul 200510:42 amRNSHolding(s) in Company
18th Jul 20053:52 pmRNSHolding(s) in Company
15th Jul 200512:54 pmRNSAdditional Listing
12th Jul 20057:30 amRNSIndustry Award Win
28th Jun 200511:47 amRNSAdditional Listing- Replace
28th Jun 200510:12 amRNSAdditional Listing
17th Jun 20059:48 amRNSHolding(s) in Company
16th Jun 200511:09 amRNSHolding(s) in Company
26th May 200511:53 amRNSAnnual Report and Accounts
25th May 20051:15 pmRNSAGM Statement
18th Apr 20053:24 pmRNSAdditional Listing
22nd Mar 20057:02 amRNSFinal Results
28th Feb 20059:33 amRNSNotice of Results
4th Feb 20051:18 pmRNSHolding(s) in Company
27th Jan 20057:00 amRNSTrading Statement
10th Jan 200511:35 amRNSAdd. Listing/Director s/hldng

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.